Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics

for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05056818

Recruiting

A First-in-Human, Phase 1/2 Study of LAT010 in Patients with Advanced Solid Tumors (LIGHTSPEED-1)

for
Advanced Solid Tumor
Location: Margate FL
Sponsor: Latticon Antibody Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06277219

Phase 1, Phase 2, Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Solid Tumors, HER2 Mutation
Location: Boston MA, Toronto, Fort Myers FL, Cleveland OH,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06760819

Phase 2, Recruiting

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT05108519

Recruiting

Rowing Following Breast Cancer Chemotherapy

for
Breast Cancer Survivors
Location: Gainesville FL
Sponsor: University of Florida

Sex: Female

Age: 40 - 70+

Code: NCT05848141

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Houston TX, Irving TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06167317

Phase 1, Recruiting

Effects of Treatments on Atopic Dermatitis

for
Eczema, Dermatitis, Skin Diseases, Genetic, Dermatitis, Atopic,
Location: Bethesda MD
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 2 - 50

Code: NCT01631617

Phase 2, Recruiting

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

for
Brain Metastases, Solid Tumors
Location: Boston MA, New York city NY, Pittsburgh PA
Sponsor: Aposense Ltd.

Sex: All

Age: 18+

Code: NCT00805636

Phase 2, Recruiting

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, Fairfax VA, Grand Rapids MI, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06797336

Phase 1, Recruiting

Vit D3 and Omega 3 in Chemo Induced Neuropathy

for
Cancer, Neuropathy
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT02294149

Phase 3, Recruiting

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

for
Recurrent or Refractory Solid Tumors, Ewing Sarcoma,
Location: Cincinnati OH, Milwaukee WI, Dallas TX,
Sponsor: South Plains Oncology Consortium

Sex: All

Age: 1 - 20

Code: NCT02013336

Phase 1, Recruiting

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

for
Breast Cancer
Location: Montreal, Ottawa, London
Sponsor: Jewish General Hospital

Sex: All

Age: 18+

Code: NCT04874064

Recruiting

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

for
Acute Leukemia, Newly Diagnosed, Relapsed
Location: Hartford CT, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT02677064

Recruiting

Acetylamantadine Excretion by Cancer Patients

for
Cancer
Location: Winnipeg
Sponsor: University of Manitoba

Sex: All

Age: 18 - 70+

Code: NCT02277938

Recruiting

Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

for
Metastatic Breast Cancer, Brain Metastases
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 19 - 70+

Code: NCT03449238

Phase 1, Phase 2, Recruiting

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

for
Body Mass Index Greater Than or Equal to 30,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT04003038

Recruiting

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

for
Cancer Patients
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT01742143

Recruiting

Care Coordination Educational Intervention Study for Patients From Rural Areas With Early Stage Cancer

for
Cancer
Location: Burlington VT
Sponsor: University of Vermont Medical Center

Sex: All

Age: 18+

Code: NCT05723250

Recruiting

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

for
Breast Cancer
Location: Providence RI, Wynnewood PA, Miami FL, Naples FL,
Sponsor: Sanarus Technologies, Inc.

Sex: Female

Age: 50+

Code: NCT01992250

Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Providence RI, Fairfax VA, Charlottesville VA,
Sponsor: Nimbus Wadjet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06898450

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial